Journal
LAB ON A CHIP
Volume 17, Issue 18, Pages 3026-3036Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c7lc00462a
Keywords
-
Categories
Funding
- Intramural NIH HHS [Z99 TR999999] Funding Source: Medline
Ask authors/readers for more resources
The high rate of failure during drug development is well-known, however recent advances in tissue engineering and microfabrication have contributed to the development of microphysiological systems (MPS), or 'organs-on-chips' that recapitulate the function of human organs. These 'tissue chips' could be utilized for drug screening and safety testing to potentially transform the early stages of the drug development process. They can also be used to model disease states, providing new tools for the understanding of disease mechanisms and pathologies, and assessing effectiveness of new therapies. In the future, they could be used to test new treatments and therapeutics in populations - via clinical trials-on-chips - and individuals, paving the way for precision medicine. Here we will discuss the wide-ranging and promising future of tissue chips, as well as challenges facing their development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available